Endo Pharmaceuticals Holdings Inc
10% Owner
Endo Pharmaceuticals Holdings Inc10% Owner
Endo Pharmaceuticals Holdings Inc insider trades: Penwest Pharmaceuticals (PPCO) SEC Form 4 filings
10% Owner, Penwest Pharmaceuticals 7 Form 4 filings
7
Form 4 filings
last Nov 8, 2010
1
Other transactions
filings
2
Companies
Companies
Where Endo Pharmaceuticals Holdings Inc reports to the SEC
About Endo Pharmaceuticals Holdings Inc's insider trades
Endo Pharmaceuticals Holdings Inc is a 10% owner of Penwest Pharmaceuticals (PPCO). It has not reported an open-market purchase or sale.
Its filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PPCO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.